Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06993038

Adenosine vs Diltiazem for Treatment of SVT in the ED

COMparison of Adenosine Versus Diltiazem FOR Supraventricular Tachycardia in the ED (COMFORT-ED) - Pilot Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Anne E. Zepeski · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.

Conditions

Interventions

TypeNameDescription
DRUGadenosineIV adenosine at standard doses for SVT (6 mg, 12 mg)
DRUGdiltiazemIV diltiazem at standard doses for SVT (0.25 mg/kg)

Timeline

Start date
2025-08-01
Primary completion
2026-07-01
Completion
2026-12-01
First posted
2025-05-28
Last updated
2025-09-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06993038. Inclusion in this directory is not an endorsement.